Hypokit batch withdrawn from market.
The state pharmaceutical services on Monday recalled from the Cypriot market the medicinal product of Novo Nordisk GlucaGenA HypoKit, batch number FS6X535.
GlucaGenA HypoKit is used for the treatment of severe hypoglycemia (low blood sugar) in people with diabetes.
In an announcement, the pharmaceutical services said that following an investigation by Novo Nordisk, it emerged that a small number of needles, 0.006per cent, in some batches of GlucaGenA HypoKit, had detached from the syringe during use. The recall followed a decision of the Drugs Council.
"For the safety of patients the pharmaceutical services recall the affected batch from wholesalers, hospitals, pharmacies, and patients who have in their possession a product of the batch in question," the announcement said.
The number and expiration date of the recalled batch of GlucaGenA HypoKit are:
Lot number: FS6X535
Expiration date: 08/2018
In the case where patients or caregivers have in their possession a GlucaGenA HypoKit they are urged to check the lot number printed on the product's packaging.
The pharmaceutical services recommend to patients who hold this product with the lot number FS6X535 to return it directly to the pharmacy they bought it from to get a free replacement with a new GlucaGenA HypoKit.
"Those holding a GlucaGenA HypoKit with a different lot number, there is no cause for concern and may use the product," it said.
For more information, call 22 608618.
The post Hypokit batch withdrawn from market appeared first on Cyprus Mail .
Copyright [c] Cyprus Mail 2016 Provided by SyndiGate Media Inc. ( Syndigate.info ).
|Printer friendly Cite/link Email Feedback|
|Publication:||Cyprus Mail (Cyprus)|
|Date:||Sep 12, 2016|
|Previous Article:||CABS accuses British bases of inaction on bird trapping, bases hit back.|
|Next Article:||Turkey has evidence that removed mayors supported Kurdish militants.|